Log In
BCIQ
Print this Print this
 

AntiFluCide-1, Influenza nanoviricides

  Manage Alerts
Collapse Summary General Information
Company NanoViricides Inc.
DescriptionTargeted antiviral nanomedicines designed to specifically attack and dismantle H5N1 bird flu and common influenza viruses
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsTreat common influenza and bird flu (H5N1)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today